)
Edge20 Feb 2026
Dollar General: The Rural Retailer Playbook
How Dollar General built a small-box empire across rural America, scaling value and convenience into one of retail's most durable business models.
Bioretec
Bioretec (BRETEC) investor relations material
Bioretec Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary13 Feb, 2026
Executive summary
2025 was a foundational rebuilding year with major C-suite changes, including new CEO and CFO appointments, five new management team members, and a revamped U.S. distribution model to enhance commercial growth and operational agility.
Achieved significant regulatory milestones: third FDA Breakthrough Device Designation for RemeOs DrillPin, CE mark approval for RemeOs Trauma Screw, and CMS Transitional Pass-Through Payment status.
Enhanced commercial strategy with direct U.S. sales growth, expanded KOL program, and new distribution partners in key global markets.
Updated strategic priorities and financial targets for 2026–2028, focusing on commercial leadership, innovation, and evidence generation for breakthrough products.
Commercial momentum increased in key markets, with direct U.S. sales growing for three consecutive quarters and new product launches planned.
Financial highlights
Net sales for 2025 were €3.52 million, down 22.5% year-over-year from €4.54 million in 2024, with H2 net sales falling 41.7%.
EBITDA was -€8.48 million, compared to -€4.05 million in 2024; net loss for the period was -€9.48 million, compared to -€4.61 million in 2024.
Cash and cash equivalents at year-end were €4.13 million, a 34.4% decrease.
One-off items in 2025 included €1.1 million related to unrepurchased inventory.
R&D expenditure rose to 85.8% of net sales, reflecting heavy investment in product development.
Outlook and guidance
New financial targets for 2026–2028: net sales exceeding €10 million by 2028 and average sales margin above 70%.
No annual guidance for 2026 is provided; focus remains on commercial growth and execution.
No expectation of cash flow positivity or profitability during the strategy period due to ongoing R&D and commercialization investments.
Acceleration toward targets depends on capital availability and execution.
The Board proposes no dividend for 2025.
Detail US contracting and pricing strategy
How does instrument registration affect OUS growth?
How does capital allocation affect 2028 targets?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Bioretec earnings date
Q1 202614 May, 2026
Bioretec
Next Bioretec earnings date
Q1 202614 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Bioretec Oy is a medical device manufacturer based in Finland, specializing in the development, manufacturing, and commercialization of bioresorbable orthopedic implants and implant materials. These products are designed for the treatment of bone and soft tissue injuries and are utilized in various surgical applications, including pediatrics, trauma surgery, and sports surgery. The company's Activa product line includes bioabsorbable biopolymer products. Bioretec Oy also has a subsidiary in Germany, BRI.Tech GmbH, and its products are used globally. The company is headquartered in Finland, and its shares are listed on the Nasdaq Helsinki.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage